SEC Form 4 · accession 0000904454-19-000155
Paratek Pharmaceuticals, Inc. · PRTK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William M. Haskel
Officer — Sr. VP, Sec. & General Counsel
Period of report
Feb 1, 2019
Accepted (ET)
Feb 4, 2019 · 4:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178711
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 1, 2019 | A | 15,000 | $0.00 | A | 113,551 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents performance-based restricted stock units ("PRSUs") granted on February 14, 2018 to the Reporting Person under the Paratek Pharmaceuticals, Inc. 2015 Equity Incentive Plan, which were earned on February 1, 2019. These PRSUs will settle in shares of Common Stock on May 8, 2020, provided that the Reporting Person remains in continuous service with Paratek Pharmaceuticals, Inc. through the settlement date.